Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, anakinra (Kineret®) cannot be endorsed for use within NHS Wales for the treatment of Familial Mediterranean Fever (FMF). |
||
|
||
Medicine details |
||
| Medicine name | anakinra (Kineret®) | |
| Formulation | 100 mg solution for injection | |
| Reference number | 4517 | |
| Indication | Treatment of Familial Mediterranean Fever (FMF). Kineret should be given in combination with colchicine, if appropriate |
|
| Company | Swedish Orphan Biovitrum Ltd | |
| BNF chapter | Musculoskeletal & joint diseases | |
| Submission type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Date of issue | 15/09/2020 | |